Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
US12054474B2 · kind B2 · utility
0Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2022 |
| Grant date | Aug 6, 2024 |
| Priority date | — |
| Expiry date | Oct 10, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. in which q, R11, R12, R13 and R14 are as defined in the specification, for use in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.